Physician Resources
IntroductionInfluenza Disease Management ProgramInfluenza Disease ModelZstatFlu InfoAdvisors & Clinical StudiesReimbursement IssuesInfluenza SurveillanceProduct FAQs


Order ZstatFlu
Order ZstatFlu®.
Introduction
Four Steps
Specificity/Sensitivity
Portability
Technology Advantage
Advantages for Physicians
Advantages for Patients
Package Insert

ZstatFlu® is the first rapid, point-of-care test for influenza A and B. The chart below compares current flu testing methods.

   ZstatFlu®  Flu
 OIA
 Directigen FluA
 Flu A
Viral Culture Isolation
Flu Strains Detected All A & B strains, including H5N1 A & B strains A strains only A & B strains
Test Location point of care commercial lab commercial lab index commercial lab
Time Required <2 min. hands-on time plus 20 min. incubation ~20 min., including multiple hands-on steps ~20 min., including multiple hands-on steps 2 to 10 days pos.
10 to 21 days neg.
Special Handling
& Transport
No. Sample can be transported within 24 hrs with no transport medium yes yes yes
Special Technical
Training
no yes yes yes
Test Complexity 4 simple steps mulitple steps; requires critical timing multiple steps; requires critical timing; toxic reagents mulitple steps
Collection Method patient-friendly throat swab nasopharyngeal wash preferred nasopharyngeal wash, nasopharyngeal swab, or throat swab nasopharyngeal wash, nasopharyngeal swab, or throat swab
Communication 2 steps: physician/nurse to patient 3 steps: lab to physician/nurse to patient 3 steps: lab to physician/nurse to patient 3 steps: lab to physician/nurse to patient
Specificity / Sensitivity 99%
68%
76%
62% for throat swab
92%
67% for throat swab
99%
100%
About UsInvestor InfoFlu101Physician ResourcesProducts & Technology HomeLinksContact UsSitemap
 
ZymeTx Web Sites:
zymetx.com
flu101.com
fluwatch.com

©2003 - ZymeTx, Inc.
ZstatFlu®, ViraZyme®,
and ViraSTAT® are trademarks of ZymeTx, Inc.